Drug Manufacturing
4 articles on Drug Manufacturing, written by Shotlee and medically reviewed for clinical accuracy.
Eli Lilly Invests $3B in China for Next-Gen Oral GLP-1 Drug Production
Eli Lilly is set to invest a substantial $3 billion in China over the next decade to bolster the production of its groundbreaking oral GLP-1 receptor agonist, Orforglipron. This strategic move aims to enhance supply chain capacity for a drug poised to treat type 2 diabetes and obesity.
8 min read
Delhi HC Rejects Stay on Order Permitting Dr. Reddy's Semaglutide Export
The Delhi High Court has upheld a previous ruling that allows Dr. Reddy's Laboratories to manufacture Semaglutide for export. This decision comes amid an ongoing patent dispute with Novo Nordisk, who claims Dr. Reddy's infringed on their Semaglutide patent.
3 min read
Dr. Reddy's Cleared by Delhi HC to Export Semaglutide Generics of Novo Nordisk
An Indian court has granted Dr. Reddy's Laboratories Ltd permission to manufacture and export generic versions of Novo Nordisk's diabetes and obesity medications. This decision comes before the global patent expirations in 2026. The ruling allows export to countries without patent protection.
2 min read
Peptide CDMO 2.0 Market Outlook to 2034: Emphasizing Integrated and Tech-Forward CDMOs
The global peptide CDMO 2.0 market is poised for substantial growth, driven by increasing demand for peptide therapeutics and advancements in manufacturing technologies. This growth is fueled by the need for flexible, scalable, and efficient peptide production to meet the demands of both established pharmaceutical companies and emerging biotechs.
6 min read